Company / Free Cash Flow per Share
AXIM BIOTECHNOLOGIES, INC. Free Cash Flow per Share History
FY2015-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
-$0.01
FY2023
5-year range
-$0.03 / -$0.01
FY2019-FY2023
Trend
+64.0%
vs FY2022
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Free Cash Flow per Share has increased for 3 consecutive years, from $-0.05 in FY2015 to $-0.01 in FY2023.
Based on SEC 10-K filings.
-0.01 in FY2023.
Improved from $-0.03 to $-0.01 over the past 7 years.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2023, free cash flow per share increased 64.0% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -18.18 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2023 | -$0.01 | +64.0% |
| FY2022 | -$0.01 | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | -$0.03 | +29.2% |
| FY2015 | -$0.05 | - |
| FY2013 | - | - |
| FY2012 | - | - |
| FY2011 | - | - |
As of FY2023 · SEC 10-K · Updated Jun 29, 2026